Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection.

Marina Vogel-GonzálezMarc Talló-ParraVíctor Herrera-FernándezGemma Pérez-VilaróMiguel ChillónXavier Nogues Y Solans Inmaculada López MontesinosInmaculada López-MontesinosIsabel Arnau-BarrésMaria Luisa Sorli-RedóJuan Pablo HorcajadaNatalia García-Giralt Julio PascualJuana DíezRubén VicenteRobert Güerri-Fernández

Published in: Nutrients (2021)

Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency.

Keyphrases

oxide nanoparticles
coronavirus disease
sars cov
risk factors
emergency department
respiratory syndrome coronavirus
replacement therapy
climate change
double blind